The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma

Lauren Fishbein; Jaydira Del Rivero; Tobias Else; James R. Howe; Sylvia L. Asa; Debbie L. Cohen; Patricia L.M. Dahia; Douglas L. Fraker; Karyn A. Goodman; Thomas A. Hope; Pamela L. Kunz; Kimberly Perez; Nancy D. Perrier; Daniel A. Pryma; Mabel Ryder; Aaron R. Sasson; Michael C. Soulen; Camilo Jimenez

doi:10.1097/MPA.0000000000001792

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma

Lauren Fishbein, Jaydira Del Rivero, Tobias Else, James R. Howe, Sylvia L. Asa, Debbie L. Cohen, Patricia L.M. Dahia, Douglas L. Fraker, Karyn A. Goodman, Thomas A. Hope, Pamela L. Kunz, Kimberly Perez, Nancy D. Perrier, Daniel A. Pryma, Mabel Ryder, Aaron R. Sasson, Michael C. Soulen, Camilo Jimenez

Research output: Contribution to journal › Article › peer-review

58 Scopus citations

Abstract

This manuscript is the result of the North American Neuroendocrine Tumor Society consensus conference on the medical management and surveillance of metastatic and unresectable pheochromocytoma and paraganglioma held on October 2 and 3, 2019. The panelists consisted of endocrinologists, medical oncologists, surgeons, radiologists/nuclear medicine physicians, nephrologists, pathologists, and radiation oncologists. The panelists performed a literature review on a series of questions regarding the medical management of metastatic and unresectable pheochromocytoma and paraganglioma as well as questions regarding surveillance after resection. The panelists voted on controversial topics, and final recommendations were sent to all panel members for final approval.

Original language	English (US)
Pages (from-to)	469-493
Number of pages	25
Journal	Pancreas
Volume	50
Issue number	4
DOIs	https://doi.org/10.1097/MPA.0000000000001792
State	Published - 2021

Keywords

management
metastatic paraganglioma
metastatic pheochromocytoma
surveillance
treatment

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Hepatology
Endocrinology

Access to Document

10.1097/MPA.0000000000001792

Cite this

Fishbein, L., Del Rivero, J., Else, T., Howe, J. R., Asa, S. L., Cohen, D. L., Dahia, P. L. M., Fraker, D. L., Goodman, K. A., Hope, T. A., Kunz, P. L., Perez, K., Perrier, N. D., Pryma, D. A., Ryder, M., Sasson, A. R., Soulen, M. C., & Jimenez, C. (2021). The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma. Pancreas, 50(4), 469-493. https://doi.org/10.1097/MPA.0000000000001792

Fishbein, L, Del Rivero, J, Else, T, Howe, JR, Asa, SL, Cohen, DL, Dahia, PLM, Fraker, DL, Goodman, KA, Hope, TA, Kunz, PL, Perez, K, Perrier, ND, Pryma, DA, Ryder, M, Sasson, AR, Soulen, MC & Jimenez, C 2021, 'The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma', Pancreas, vol. 50, no. 4, pp. 469-493. https://doi.org/10.1097/MPA.0000000000001792

@article{3046ea6fc98e4e82b243fedb981a4038,

title = "The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma",

abstract = "This manuscript is the result of the North American Neuroendocrine Tumor Society consensus conference on the medical management and surveillance of metastatic and unresectable pheochromocytoma and paraganglioma held on October 2 and 3, 2019. The panelists consisted of endocrinologists, medical oncologists, surgeons, radiologists/nuclear medicine physicians, nephrologists, pathologists, and radiation oncologists. The panelists performed a literature review on a series of questions regarding the medical management of metastatic and unresectable pheochromocytoma and paraganglioma as well as questions regarding surveillance after resection. The panelists voted on controversial topics, and final recommendations were sent to all panel members for final approval.",

keywords = "management, metastatic paraganglioma, metastatic pheochromocytoma, surveillance, treatment",

author = "Lauren Fishbein and {Del Rivero}, Jaydira and Tobias Else and Howe, {James R.} and Asa, {Sylvia L.} and Cohen, {Debbie L.} and Dahia, {Patricia L.M.} and Fraker, {Douglas L.} and Goodman, {Karyn A.} and Hope, {Thomas A.} and Kunz, {Pamela L.} and Kimberly Perez and Perrier, {Nancy D.} and Pryma, {Daniel A.} and Mabel Ryder and Sasson, {Aaron R.} and Soulen, {Michael C.} and Camilo Jimenez",

year = "2021",

doi = "10.1097/MPA.0000000000001792",

language = "English (US)",

volume = "50",

pages = "469--493",

journal = "Pancreas",

issn = "0885-3177",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma

AU - Fishbein, Lauren

AU - Del Rivero, Jaydira

AU - Else, Tobias

AU - Howe, James R.

AU - Asa, Sylvia L.

AU - Cohen, Debbie L.

AU - Dahia, Patricia L.M.

AU - Fraker, Douglas L.

AU - Goodman, Karyn A.

AU - Hope, Thomas A.

AU - Kunz, Pamela L.

AU - Perez, Kimberly

AU - Perrier, Nancy D.

AU - Pryma, Daniel A.

AU - Ryder, Mabel

AU - Sasson, Aaron R.

AU - Soulen, Michael C.

AU - Jimenez, Camilo

PY - 2021

Y1 - 2021

N2 - This manuscript is the result of the North American Neuroendocrine Tumor Society consensus conference on the medical management and surveillance of metastatic and unresectable pheochromocytoma and paraganglioma held on October 2 and 3, 2019. The panelists consisted of endocrinologists, medical oncologists, surgeons, radiologists/nuclear medicine physicians, nephrologists, pathologists, and radiation oncologists. The panelists performed a literature review on a series of questions regarding the medical management of metastatic and unresectable pheochromocytoma and paraganglioma as well as questions regarding surveillance after resection. The panelists voted on controversial topics, and final recommendations were sent to all panel members for final approval.

AB - This manuscript is the result of the North American Neuroendocrine Tumor Society consensus conference on the medical management and surveillance of metastatic and unresectable pheochromocytoma and paraganglioma held on October 2 and 3, 2019. The panelists consisted of endocrinologists, medical oncologists, surgeons, radiologists/nuclear medicine physicians, nephrologists, pathologists, and radiation oncologists. The panelists performed a literature review on a series of questions regarding the medical management of metastatic and unresectable pheochromocytoma and paraganglioma as well as questions regarding surveillance after resection. The panelists voted on controversial topics, and final recommendations were sent to all panel members for final approval.

KW - management

KW - metastatic paraganglioma

KW - metastatic pheochromocytoma

KW - surveillance

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85105286819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85105286819&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000001792

DO - 10.1097/MPA.0000000000001792

M3 - Article

C2 - 33939658

AN - SCOPUS:85105286819

SN - 0885-3177

VL - 50

SP - 469

EP - 493

JO - Pancreas

JF - Pancreas

IS - 4

ER -

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this